本文首发于公众号"私募排排网"。 （点击↑↑ 上图查看详情 ） 今年以来，A股继续迎来强劲的上涨，其中沪指创下近十年新高；创业板指年内最新涨幅达到约45%，领衔A股三大主要股指。板块方面，近 日，以算力为核心的新科技板块，俨然成为撬动指数上涨的主引擎。在此基础上，不少近5年才成立的新锐私募崭露头角，成为私募市场上一股 重要的力量。 （注：本文业绩数据截至2025年9月12日，近5年成立的新锐私募即2020年9月12日后成立的私募） 0 1 私募公司：北京禧悦夺冠！量化私募巨量均衡进入 从私募公司的角度看，近5年成立的新锐私募共有1056家，其中今年来至少有3只产品符合排名规则的私募共有60家，收益20强的公司的上榜"门 槛"为 *** %。（ 点此查看收益 ） [应监管要求，私募基金不能公开展示业绩，文中涉及收益数据用***替代，合格投资者可扫描图中二维码或点击文末阅读原文，查看收益数据。] 在这20家私募中，主观私募共有12家，量化私募、混合型（"主观+量化"）私募各有4家。从公司规模来看，这20家私募的管理规模均不足50 亿。 10 强 | 排名 | 公司简称 | 实控人 | | 公司规模 投资模式 核心 ...

Core Viewpoint - The A-share market showed strong performance in August, with major indices rising significantly, yet the excess returns of stock strategy private equity products were disappointing, marking the worst monthly performance of the year [1][2]. Group 1: Market Performance - In August, the Shanghai Composite Index rose by 7.97%, the Shenzhen Component Index increased by 15.32%, and the ChiNext Index surged over 24% [1]. - Despite the strong market, the average excess return of 3,122 stock strategy private equity products was -1.97%, the worst monthly performance this year [1]. Group 2: Quantitative vs. Subjective Strategies - Quantitative private equity products experienced a notable decline, with an average excess return of -3.94% in August, while subjective private equity products had an average excess return of -1.00% [1]. - The significant decline in quantitative products is attributed to a reversal in style, particularly the outperformance of large-cap stocks over small-cap stocks, and severe sector differentiation due to rapid growth in financing scale [1][2]. Group 3: Consistent Performers - As of August 2025, only 95 stock strategy private equity products achieved positive excess returns for eight consecutive months, representing about 3% of the total [2]. - Among private equity firms with over 10 billion in assets, 46 products achieved positive excess returns for eight consecutive months, all of which were quantitative products, with an average excess return of 0.63% in August and 17.91% year-to-date [3]. Group 4: Top Performers by Asset Size - In the 20-100 billion category, 14 products achieved positive excess returns for eight consecutive months, with an average excess return of 1.83% in August and 22.48% year-to-date [7]. - The top three products in this category were "New Thinking Multi-Strategy 3", "Pansong Micro-Cap Index Enhanced 1", and "Giraffe 7", with year-to-date excess returns of ***% [11]. Group 5: Small and Emerging Firms - In the 5-20 billion category, 13 products achieved positive excess returns for eight consecutive months, with an average excess return of 5.34% in August and 57.58% year-to-date [13]. - The leading product in the 0-5 billion category was "Zijin Yunsong", achieving a year-to-date excess return of ***% [18].